life scienc tool diagnost forecast chang
ep ahead consensu ep
exceed estim lower revenu off-set better profit factor
line ad importantli refin guidanc maintain
ebitda target boost midpoint ep rang larg reflect
factor line said acknowledg guidanc rang still rel
broad ep lift ep
reflect beat well lower interest expens lower tax rate
balanc year
revenu lightminer nut /perf product culprit profit ahead revenu
fell well plan estimate despit better anim health experi
vs estimate organ basi anim health sale improv declin
mfa eas asf china partial off-set domest strength nutrit
spec aggress view lower-than-expect
osprey contribut segment growth ad million note strength
domest dairi poultri vaccin vs estimate rebound easi
comp intern poultri demand gross margin improv bp bp ahead
plan primarili mix sg rose bp bp plan net/net
ebitda margin deterior bp albeit bp better estim gener
million cash cash reserv stand million
reiter neutral cleanest quarter share could edg higher
follow recent pullback monument chang oper forecast pr
commentari highlight element optim allud sign us dairi
recoveri traction osprey provia prime ou demand poultri vaccin
guidanc also point continu double-digit growth albeit incl acquisit higher
margin nutrit spec vaccin said remain transit year
necessari invest support futur growth includ pipelin develop facil
expans sale forc initi new product commerci await greater
clariti success front share current trade ep
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
charl martineau univers toronto justifi discount diversifi industri leader
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
lead manufactur anim health product concentr
product anim product prevent control treat diseas
enhanc health nutrit overal product livestock
challeng relat antibiot use greater expect ramp faster-
grow subsector anim health vaccin nutrit specialti
favor epidemiolog weather macroeconom trend
influenc underli util trend consider pick
us intern livestock fundament demand
grey sky valuat assum harsher expect
regulatori challeng global use antibiot medicin feed addit
weak global livestock demand
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
